发明名称 Nucleic acids, polypeptides, and methods for modulating apoptosis
摘要 Described is an isolated nucleic acid comprising a nucleotide sequence encoding a rat apoptosis-specific eIF-5A polypeptide; a purified polypeptide comprising an amino acid sequence of the rat apoptosis-specific eIF-5A polypeptide; an isolated nucleic acid that comprises a nucleotide sequence encoding a rat apoptosis-specific DHS polypeptide; and an antisense oligonucleotide comprising a nucleotide sequence encoding a portion of the rat apoptosis-specific DHS polypeptide. Also mentioned is the use in the manufacture in the medicament of an agent that modulates apoptosis-specific eIF-5A function in a cell and the agent preferably comprises an expression vector, in a cell. Methods of identifying modulation of apoptosis comprises: (i) providing a test cell; (ii) contacting the test cell with a drug candidate; and (iii) determining whether a ratio of proliferating eIF-5A to apoptosis-specific eIF-5A in the test cell in the presence in the drug candidate has been altered, wherein alterations in the ratio of proliferating eIF-5A to apoptosis-specific eIF-5A is indicative of modulation of apoptosis and wherein the test cell is not a human cell in situ.
申请公布号 NZ536958(A) 申请公布日期 2005.12.23
申请号 NZ20030536958 申请日期 2003.05.07
申请人 SENESCO TECHNOLOGIES, INC 发明人 TAYLOR, CATHERINE;WANG, TZANN-WEI;PETROV, LARRY;CARLSON, JOHN C;NARAYANSINGH, RICHARD;THOMPSON, JOHN E;CLICHE, DOMINIC;KAUP, MARIANNE
分类号 C12N15/09;A61K31/7088;A61K35/74;A61K35/76;A61K45/00;A61K48/00;A61P1/16;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P11/06;A61P13/10;A61P13/12;A61P17/00;A61P17/02;A61P19/02;A61P19/10;A61P21/04;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/04;A61P37/06;A61P37/08;A61P43/00;C07K14/47;C12N9/00;C12N9/02;C12N9/10;C12Q1/02;C12Q1/68;H01S5/022;H01S5/024;H01S5/0683 主分类号 C12N15/09
代理机构 代理人
主权项
地址